It will be the first drug of its type in China. Today they have nothing,” said Christian Hogg, chief executive with Nasdaq-listed Chi-Med in Hong Kong. Photo: Shutterstock

CK Hutchison’s pharma unit to partner with Eli Lilly on first home-grown colorectal cancer drug in China

Shanghai-based drugmaker poised to become first domestic player to design, manufacture a medicine that could ‘significantly extend the lifespan’ of patients

TOP PICKS

It will be the first drug of its type in China. Today they have nothing,” said Christian Hogg, chief executive with Nasdaq-listed Chi-Med in Hong Kong. Photo: Shutterstock
READ FULL ARTICLE